Ceritinib in ALK-Rearranged Non―Small-Cell Lung CancerSHAW, Alice T; KIM, Dong-Wan; RIELY, Gregory J et al.The New England journal of medicine. 2014, Vol 370, Num 13, pp 1189-1197, issn 0028-4793, 9 p.Article

MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to CrizotinibLENNERZ, Jochen K; KWAK, Eunice L; SALGIA, Ravi et al.Journal of clinical oncology. 2011, Vol 29, Num 36, pp 4803-4810, issn 0732-183X, 8 p.Article

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerSHAW, Alice T; KIM, Dong-Wan; WU, Yi-Long et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2385-2394, issn 0028-4793, 10 p.Article

Crizotinib in ROS1-Rearranged Non―Small-Cell Lung CancerSHAW, Alice T; OU, Sai-Hong I; DOEBELE, Robert C et al.The New England journal of medicine. 2014, Vol 371, Num 21, pp 1963-1971, issn 0028-4793, 9 p.Article

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung CancerSOLOMON, Benjamin J; MOK, Tony; IYER, Shrividya et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2167-2177, issn 0028-4793, 11 p.Article